Evaluation of CD44 and CD133 as cancer stem cell markers for colorectal cancer

Author：

ISSN： 1021-335X

Source： Oncology Reports, Vol.28, Iss.4, 2012-01, pp. : 1301-1308

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prognostic Significance of the Cancer Stem Cell Markers CD133, CD44, and CD166 in Colorectal Cancer

By Horst David Kriegl Lydia Engel Jutta Kirchner Thomas Jung Andreas

Cancer Investigation, Vol. 27, Iss. 8, 2009-10 ,pp. : 844-850

Informa Healthcare

Access to resources Recommend Favorite

Colon cancer stem cell markers CD44 and CD133 in patients with colorectal cancer and synchronous hepatic metastases

International Journal of Oncology, Vol. 46, Iss. 4, 2015-01 ,pp. : 1582-1588

Spandidos Publications

Access to resources Recommend Favorite

Expression and clinical significance of colorectal cancer stem cell marker EpCAMhigh/CD44+ in colorectal cancer

Oncology Letters, Vol. 7, Iss. 5, 2014-01 ,pp. : 1544-1548

Spandidos Publications

Access to resources Recommend Favorite

Surgically resected human tumors reveal the biological significance of the gastric cancer stem cell markers CD44 and CD26

Oncology Letters, Vol. 9, Iss. 5, 2015-01 ,pp. : 2361-2367

Spandidos Publications

Access to resources Recommend Favorite

Expression profiling of stem cell signaling alters with spheroid formation in CD133high/CD44high prostate cancer stem cells

Oncology Letters, Vol. 7, Iss. 6, 2014-01 ,pp. : 2103-2109

Spandidos Publications

Access to resources Recommend Favorite